The Effect of Hyoscine-N-butylbromide (HBB, Buscopan) in Augmented Labour Among Primigravidae

• Status: Recruiting
• Trial end date: 2020-06-30
• Target enrollment: 0
• Participant gender: Female

Summary

This study compares the duration of active phase of labour in women who received buscopan and those who don't.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: National University of Malaysia
• Treatments: Butylscopolammonium Bromide; Scopolamine

Criteria

Inclusion Criteria:

• Primigravida

• Vertex presentation

• Term gestation (37-41w)

• Active phase of labor (4cm with regular contraction at least 2:10)

• Spontaneous labor

• Oxytocin augmentation

• Maternal height ≥150cm

Exclusion Criteria:

• Multiple pregnancies

• Previous uterine surgery

• Hypertensive disease in pregnancy

• Gestational diabetes on treatment

• Clinical estimation of fetal weight >3.8kg

• Induction of labor

• Meconium stained liquor

• Allergy to hyoscine

• Medical contraindication to hyoscine (i.e Myasthenia gravis, glaucoma, megacolon)